{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:01:30Z","timestamp":1787061690412,"version":"build-2736575974"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alopecia areata (AA) is an autoimmune disease that causes recurrent hair loss. No treatment has been effective in the long term because of the unstable efficacy and possible side effects. AA is primarily driven by Th1-type inflammation, centred around CD8+ T cells and interferon-\u03b3 (IFN-\u03b3). Recent studies have revealed that the Janus kinase (JAK) family is also involved in the pathogenesis of AA, leading to JAK inhibitors emerging as a treatment for AA. We present a case of a 39-year-old Japanese woman with severe AA who exhibited a Severity of Alopecia Tool (SALT) score 80 accompanied by atopic dermatitis (AD). Despite conventional treatments, the condition worsened from a SALT score of 80 to 100. We subsequently attempted treatment with an excimer laser (EL), but no hair regrowth was observed. However, the introduction of 0.5% delgocitinib ointment in combination with EL led to complete hair regrowth beginning 2\u2005months later, with complete remission achieved after 1\u2005year. This case highlights the potential efficacy of combining delgocitinib ointment with EL in treating severe AA, particularly in patients with AD. The findings suggest that this combination therapy may provide a safer and more effective alternative to oral JAK inhibitors. Nevertheless, further studies are needed to elucidate the underlying mechanisms and fully evaluate the therapeutic synergy.<\/jats:p>","DOI":"10.1093\/skinhd\/vzaf013","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:19:05Z","timestamp":1739459945000},"page":"154-157","source":"Crossref","is-referenced-by-count":4,"title":["A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8419-8929","authenticated-orcid":false,"given":"Yukito","family":"Kakeji","sequence":"first","affiliation":[{"name":"Department of Dermatology, Osaka Red Cross Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kogame","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto University Graduate School of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Osaka Red Cross Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9610-4952","authenticated-orcid":false,"given":"Naotomo","family":"Kambe","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto University Graduate School of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-0554","authenticated-orcid":false,"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto University Graduate School of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2025051214211224100_vzaf013-B1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia areata: an update on etiopathogenesis, diagnosis, and management","volume":"61","author":"Zhou","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025051214211224100_vzaf013-B2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","volume":"77","author":"Guttman-Yassky","year":"2022","journal-title":"Allergy"},{"key":"2025051214211224100_vzaf013-B3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20312","article-title":"Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: a 24-week Italian study","author":"Piraccini","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025051214211224100_vzaf013-B4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","article-title":"Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial","volume":"401","author":"King","year":"2023","journal-title":"Lancet"},{"key":"2025051214211224100_vzaf013-B5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00403-022-02336-0","article-title":"A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata","volume":"315","author":"Mikhaylov","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"2025051214211224100_vzaf013-B6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2019.10.016","article-title":"Ruxolitinib cream for the treatment of patients with alopecia areata: A2-part, double-blind, randomized, vehicle-controlled phase 2 study","volume":"82","author":"Olsen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025051214211224100_vzaf013-B7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.15489","article-title":"JAK inhibitors for alopecia areata: a systematic review and meta-analysis","volume":"33","author":"Phan","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025051214211224100_vzaf013-B8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/09546634.2019.1687825","article-title":"The effects of 308-nm excimer laser on the infiltration of CD4+, CD8+ T-cells, and regulatory T cells in the lesional skin of patients at active and stable stages of nonsegmental vitiligo","volume":"32","author":"Zhang","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"2025051214211224100_vzaf013-B9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/CCID.S310487","article-title":"Effects of UV induced-photoaging on the hair follicle cycle of C57BL6\/J mice","volume":"14","author":"Zhai","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2025051214211224100_vzaf013-B10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/phpp.12596","article-title":"Excimer laser\/light treatment of alopecia areata: a systematic review and meta-analyses","volume":"36","author":"Lee","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025051214211224100_vzaf013-B11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1684\/ejd.2023.4513","article-title":"Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser","volume":"33","author":"Murakami","year":"2023","journal-title":"Eur J Dermatol"},{"key":"2025051214211224100_vzaf013-B12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/09546634.2020.1735615","article-title":"Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and meta-analysis","volume":"33","author":"Phan","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2025051214211224100_vzaf013-B13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"2025051214211224100_vzaf013-B14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1189\/jlb.1209772","article-title":"Regulation of the T helper cell type 2 (th2)\/T regulatory cell (treg) balance by IL-4 and STAT6","volume":"87","author":"Chapoval","year":"2010","journal-title":"J Leukoc Biol"},{"key":"2025051214211224100_vzaf013-B15","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.immuni.2022.08.001","article-title":"Innate type 2 immunity controls hair follicle commensalism by Demodex mites","volume":"55","author":"Ricardo-Gonzalez","year":"2022","journal-title":"Immunity"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/5\/2\/154\/62883395\/vzaf013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/5\/2\/154\/62883395\/vzaf013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T14:21:22Z","timestamp":1747059682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/5\/2\/154\/8107658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5,12]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf013","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,4]]}}}